Ligand Pharmaceuticals

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Ligand Pharmaceuticals
Apr 19, 2025, 18:20 | Blog
Todd Davis: Ligand Pharmaceuticals announces agreement to combine Pelthos with Channel Therapeutics
Todd Davis, Chief Executive Officer and Director of Ligand Pharmaceuticals, shared a post on LinkedIn:…
Oct 31, 2024, 14:06 | Blog
Todd Davis: Swissmedic has approved FILSPARI for the treatment of adults with primary IgA nephropathy
Todd Davis, Chief Executive Officer & Director at Ligand Pharmaceuticals, shared on LinkedIn: "We have…
Sep 13, 2024, 14:34 | Blog
Todd Davis: Ligand's announcement on the FILSPARI full FDA approval
Todd Davis, CEO at Ligand Pharmaceuticals, shared on LinkedIn: "We have had significant positive momentum…
Aug 10, 2024, 17:08 | Blog
Todd Davis: Expending Portfolio and Setting ambitious growth targets
Todd Davis, CEO at Ligand Pharmaceuticals, shared on LinkedIn: "On the Ligand Pharmaceuticals earnings call this…
Jul 21, 2024, 12:10 | Blog
invIOs selects lead candidate to IND-enable studies in glioblastoma and melanoma
invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, announced that…
Jul 10, 2024, 05:18 | Insight
APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million
APEIRON Biologics AG (“APEIRON”), a leading Austrian biotech company, today announced that its shareholders have…
Jul 1, 2024, 13:53 | Drugs
Todd Davis: Approval of Verona Pharma’s Ohtuvayre
Todd Davis, CEO at Ligand Pharmaceuticals, shared on LinkedIn: "When I stepped in as CEO…
May 13, 2024, 07:25 | Blog
Partnership between Ligand Pharmaceuticals and Agenus
Ligand Pharmaceuticals shared on their LinkedIn page: "We are excited to announce our latest royalty…
May 12, 2024, 03:08 | Blog
CEO of Agenus, Garo Armen shares details on our royalty financing agreement with Ligand Pharmaceuticals
Agenus shared on LinkedIn: “‘With this infusion of capital, we are poised to accelerate the…
May 9, 2024, 12:46 | Blog
Zack Armen: A major transaction with Ligand Pharmaceuticals and Agenus
Zack Armen, Head of Investor Relations at Agenus, shared a post on LinkedIn: ''Yesterday we…
All: 10 Posts: 1 - 100
Special Coverage